Roland Rott - Nov 5, 2024 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
CEO, Imaging
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol
GEHC
Transactions as of
Nov 5, 2024
Transactions value $
-$623,059
Form type
4
Date filed
11/6/2024, 05:53 PM
Previous filing
Sep 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common Stock, par value $0.01 per share Options Exercise $536K +13.3K +54.63% $40.40 37.6K Nov 5, 2024 Direct
transaction GEHC Common Stock, par value $0.01 per share Tax liability -$850K -9.7K -25.81% $87.65 27.9K Nov 5, 2024 Direct F1
transaction GEHC Common Stock, par value $0.01 per share Sale -$309K -3.58K -12.83% $86.48 24.3K Nov 6, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Options Exercise $0 -13.3K -100% $0.00 0 Nov 5, 2024 Common Stock, par value $0.01 per share 13.3K $40.40 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by GE HealthCare Technologies Inc. ("GE HealthCare") to satisfy the exercise price and tax withholding obligations in connection with the net settlement of the options, and does not represent a sale of any shares by the Reporting Person.
F2 The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $86.48 to $86.54, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
F3 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of GE HealthCare common stock by GE to holders of GE common stock on a pro-rata basis, of which 100% was fully exercisable immediately.